Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NEU2 | Q9Y3R4 | 11/20 | 0.38 |
| ▸ | NEU1 | Q99519 | 8/20 | 0.38 |
| ▸ | NEU3 | Q9UQ49 | 8/20 | 0.38 |
| ▸ | NEU4 | Q8WWR8 | 6/20 | 0.38 |
| ▸ | FUCA1 | P04066 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12068163 | 1.00 | NEU2 (0.38) | NEU2NEU1NEU3NEU4FUCA1 | |
| SCHEMBL17722419 | 1.00 | NEU2 (0.38) | NEU2NEU1NEU3NEU4FUCA1 | |
| SCHEMBL25060228 | 1.00 | NEU2 (0.38) | NEU2NEU1NEU3NEU4FUCA1 | |
| SCHEMBL22919828 | 0.88 | NEU2 (0.40) | NEU2NEU1NEU3NEU4ALDH1A1 | |
| SCHEMBL9697618 | 0.84 | NFKB1 (0.38) | NEU2NEU1NEU3NEU4FUCA1 | |
| SCHEMBL21067554 | 0.79 | NEU2 (0.37) | NEU2NEU1NEU3NEU4 | |
| SCHEMBL15227226 | 0.79 | NEU2 (0.37) | NEU2NEU1NEU3NEU4 | |
| SCHEMBL12997167 | 0.79 | NEU2 (0.37) | NEU2NEU1NEU3NEU4 | |
| SCHEMBL7151188 | 0.76 | NEU2 (0.35) | NEU2NEU1NEU3NEU4 | |
| SCHEMBL22731169 | 0.76 | NEU1 (0.37) | NEU2NEU1NEU3NEU4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7687274-B2 | Method for determining specific groups constituting heparins or low molecular weight heparins | AVENTIS PHARMA S.A. (FR) | 2010-03-30 | — | — | US | disclosed |
| US-20090023171-A1 | Method for determining specific groups constituting heparins or low molecular weight heparins | VISKOV CHRISTIAN | 2009-01-22 | — | — | US | disclosed |
| US-20080171367-A1 | Heparan Sulfate Glycosaminoglycan Lyase and Uses Thereof | MOMENTA PHARMACEUTICALS, INC. (US) | 2008-07-17 | — | — | US | disclosed |